At a Glance
| 5F-PB-22 | AB-FUBINACA | |
|---|---|---|
| Class | Cannabinoid | Cannabinoid |
| Common Dose (smoked) | 3–5 mg | 2–3 mg |
| Total Duration | 0.6–1.3 hrs | 0.6–1.5 hrs |
| Routes | oralsmoked | smoked |
5F-PB-22, a Cannabinoid, and AB-FUBINACA, a Cannabinoid, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Cannabinoids, meaning they share a common pharmacological foundation. They share 23 documented effects in common, with 7 effects unique to 5F-PB-22 and 11 unique to AB-FUBINACA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 5F-PB-22 | AB-FUBINACA | |
|---|---|---|
| Class | Cannabinoid | Cannabinoid |
| Common Dose (smoked) | 3–5 mg | 2–3 mg |
| Total Duration | 0.6–1.3 hrs | 0.6–1.5 hrs |
| Routes | oralsmoked | smoked |
| Effects | 30 documented | 34 documented |
| Level | 5F-PB-22 | AB-FUBINACA |
|---|---|---|
| Threshold | 1 mg | 1 mg |
| Light | 1–3 mg | 1–2 mg |
| Common | 3–5 mg | 2–3 mg |
| Strong | 5–8 mg | 3–5 mg |
| Heavy | 8 mg | 5 mg |
| Level | Dose |
|---|---|
| Threshold | 1 mg |
| Light | 1–3 mg |
| Common | 3–5 mg |
| Strong | 5–8 mg |
| Heavy | 8 mg |
5F-PB-22
AB-FUBINACA
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.